Comparison - EBS - NYSE - Weiss Ratings

Weiss Ratings	EBS - NYSE	Click to Compare	Click to Compare	Click to Compare
Rating	D
Reward Index	Very Weak
Risk Index	Weak
Risk Grade	D
Reward Grade	E

Rating Factors	EBS - NYSE	Click to Compare	Click to Compare	Click to Compare
Dividend Index	--
Growth Index	Very Weak
Efficiency Index	Very Weak
Solvency Index	Good
Total Return Index	Weak
Volatility Index	Weak

Beta / Standard Deviation	EBS - NYSE	Click to Compare	Click to Compare	Click to Compare
Beta	4.34

Price History	EBS - NYSE	Click to Compare	Click to Compare	Click to Compare
7-Day Total Return	-1.55%
30-Day Total Return	-48.60%
60-Day Total Return	-32.67%
90-Day Total Return	-36.98%
Year to Date Total Return	-44.40%
1-Year Total Return	142.98%
2-Year Total Return	-41.13%
3-Year Total Return	-84.58%
5-Year Total Return	-90.05%
52-Week High % Change	-63.51%
52-Week Low % Change	202.73%

Price	EBS - NYSE	Click to Compare	Click to Compare	Click to Compare
52-Week High Price	$15.10
52-Week Low Price	$1.82
52-Week Low Price (Date)	Apr 18, 2024
52-Week High Price (Date)	Jul 30, 2024

Valuation	EBS - NYSE	Click to Compare	Click to Compare	Click to Compare
Market Cap	299.40M
Enterprise Value	876.00M
Price/Earnings (TTM)	--
Earnings Per Share (TTM)	-3.73
Earnings Per Share Growth	-74.97%
Price/Earnings To Growth	--
Price/Sales (TTM)	0.29
Price/Book (Q)	0.62
Enterprise Value/Revenue (TTM)	0.84
Price	$5.71
Enterprise Value/EBITDA (TTM)	16.22
Enterprise Value/EBIT	-16.98
Market Cap Category	Micro Cap

Dividends and Shares	EBS - NYSE	Click to Compare	Click to Compare	Click to Compare
Shares Outstanding	54.20M
Dividend Yield	--
Div. Per Share (Most Recent)	--
Dividend Per Share (TTM)	--
Payout Ratio (TTM)	--
Dividend Per Share (Most Recent)	--

Company Info	EBS - NYSE	Click to Compare	Click to Compare	Click to Compare
Phone Number	240 631 3200
Address	400 Professional Drive Gaithersburg, MD 20879
Website	www.emergentbiosolutions.com
Country	United States
Year Founded	1998

Profitability	EBS - NYSE	Click to Compare	Click to Compare	Click to Compare
Operating Margin (TTM)	-4.94%
Profit Margin	-18.26%

Management Effectiveness	EBS - NYSE	Click to Compare	Click to Compare	Click to Compare
Return on Assets	-2.01%
Return on Equity	--

Income Statement	EBS - NYSE	Click to Compare	Click to Compare	Click to Compare
Revenue (TTM)	1.04B
Total Revenue (TTM)	1.04B
Revenue Per Share	$19.25
Gross Profit (TTM)	376.00M
EBITDA (TTM)	54.00M
EBIT (TTM)	-51.60M
Net Income (TTM)	-190.60M
Net Income Avl. to Common (TTM)	-190.60M
Total Revenue Growth (Q YOY)	-29.61%
Earnings Growth (Q YOY)	36.77%
EPS Diluted (TTM)	-3.73
EPS Diluted Growth (Q YOY)	39.22%

Balance Sheet	EBS - NYSE	Click to Compare	Click to Compare	Click to Compare
Cash and Short-Term Inv. (Q)	99.50M
Cash Per Share (Q)	$1.84
Total Current Assets (Q)	598.70M
Total Preferred Equity (Q)	--
Total Equity (Q)	482.80M
Current Ratio (Q)	3.687
Book Value Per Share (Q)	$8.89
Total Assets (Q)	1.39B
Total Current Liabilities (Q)	162.40M
Total Debt (Q)	676.10M
Total Liabilities (Q)	906.90M
Total Common Equity (Q)	482.80M

Cash Flow	EBS - NYSE	Click to Compare	Click to Compare	Click to Compare
Cash from Investing (TTM)	125.20M
Cash from Financing (TTM)	-190.00M
Net Change in Cash (TTM)	-6.10M
Levered Free Cash Flow (TTM)	58.88M
Cash from Operations (TTM)	58.70M